APO Research

APO RESEARCH · REPORT

Biodegradable Coronary Stents

Selected research

Market Analysis & Forecast

Global Biodegradable Coronary Stents Market Analysis and Forecast 2026-2032

Market perspective

The global Biodegradable Coronary Stents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biodegradable Coronary Stents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biodegradable Coronary Stents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biodegradable Coronary Stents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biodegradable Coronary Stents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Biodegradable Coronary Stents include Abbott, Terumo, Shandong Huaan Biotechnology, Boston Scientific, Wego Healthcare, SMT, SINOMED, REVA Medical (1) and Q3 Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biodegradable Coronary Stents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biodegradable Coronary Stents, also provides the sales of main regions and countries. Of the upcoming market potential for Biodegradable Coronary Stents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biodegradable Coronary Stents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biodegradable Coronary Stents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Biodegradable Coronary Stents sales, projected growth trends, production technology, application and end-user industry.

Biodegradable Coronary Stents Segment by Company

Abbott

Terumo

Shandong Huaan Biotechnology

Boston Scientific

Wego Healthcare

SMT

SINOMED

REVA Medical (1)

Q3 Medical

Lepu Medical

Kyoto Medical

Elixir Medical

Cardionovum

Biotronik

Arterius

AMG International

Amaranth Medical

3M

Biodegradable Coronary Stents Segment by Type

Polylactic Acid (PLA)

Magnesium Alloys

Others

Biodegradable Coronary Stents Segment by Application

Percutaneous Coronary Intervention (PCI)

Post-Procedure Management

Drug-Eluting

Biodegradable Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Biodegradable Coronary Stents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Biodegradable Coronary Stents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biodegradable Coronary Stents sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biodegradable Coronary Stents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Polylactic Acid (PLA) Major Manufacturers Table 3. Magnesium Alloys Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Biodegradable Coronary Stents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Percutaneous Coronary Intervention (PCI) Major Manufacturers Table 7. Post-Procedure Management Major Manufacturers Table 8. Drug-Eluting Major Manufacturers Table 9. Biodegradable Coronary Stents Industry Trends Table 10. Biodegradable Coronary Stents Industry Drivers Table 11. Biodegradable Coronary Stents Industry Opportunities and Challenges Table 12. Biodegradable Coronary Stents Industry Restraints Table 13. Global Biodegradable Coronary Stents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Biodegradable Coronary Stents Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Biodegradable Coronary Stents Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Biodegradable Coronary Stents Revenue Market Share by Region (2021-2026) Table 17. Global Biodegradable Coronary Stents Revenue Market Share by Region (2027-2032) Table 18. Global Biodegradable Coronary Stents Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 19. Global Biodegradable Coronary Stents Sales by Region (2021-2026) & (Units) Table 20. Global Biodegradable Coronary Stents Sales by Region (2027-2032) & (Units) Table 21. Global Biodegradable Coronary Stents Sales Market Share by Region (2021-2026) Table 22. Global Biodegradable Coronary Stents Sales Market Share by Region (2027-2032) Table 23. Global Biodegradable Coronary Stents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Biodegradable Coronary Stents Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Biodegradable Coronary Stents Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Biodegradable Coronary Stents Sales Market Share by Manufacturers (2021-2026) Table 27. Global Biodegradable Coronary Stents Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Biodegradable Coronary Stents Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Biodegradable Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Biodegradable Coronary Stents Manufacturers, Product Type & Application Table 31. Global Biodegradable Coronary Stents Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Biodegradable Coronary Stents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Biodegradable Coronary Stents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2026) Table 38. Global Biodegradable Coronary Stents Revenue Market Share by Type (2027-2032) Table 39. Global Biodegradable Coronary Stents Sales by Type 2021 VS 2025 VS 2032 (Units) Table 40. Global Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 41. Global Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 42. Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2026) Table 43. Global Biodegradable Coronary Stents Sales Market Share by Type (2027-2032) Table 44. Global Biodegradable Coronary Stents Price by Type (2021-2026) & (US$/Unit) Table 45. Global Biodegradable Coronary Stents Price by Type (2027-2032) & (US$/Unit) Table 46. Global Biodegradable Coronary Stents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2026) Table 50. Global Biodegradable Coronary Stents Revenue Market Share by Application (2027-2032) Table 51. Global Biodegradable Coronary Stents Sales by Application 2021 VS 2025 VS 2032 (Units) Table 52. Global Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 53. Global Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 54. Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2026) Table 55. Global Biodegradable Coronary Stents Sales Market Share by Application (2027-2032) Table 56. Global Biodegradable Coronary Stents Price by Application (2021-2026) & (US$/Unit) Table 57. Global Biodegradable Coronary Stents Price by Application (2027-2032) & (US$/Unit) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Abbott Biodegradable Coronary Stents Product Portfolio Table 62. Abbott Recent Development Table 63. Terumo Company Information Table 64. Terumo Business Overview Table 65. Terumo Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Terumo Biodegradable Coronary Stents Product Portfolio Table 67. Terumo Recent Development Table 68. Shandong Huaan Biotechnology Company Information Table 69. Shandong Huaan Biotechnology Business Overview Table 70. Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio Table 72. Shandong Huaan Biotechnology Recent Development Table 73. Boston Scientific Company Information Table 74. Boston Scientific Business Overview Table 75. Boston Scientific Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Boston Scientific Biodegradable Coronary Stents Product Portfolio Table 77. Boston Scientific Recent Development Table 78. Wego Healthcare Company Information Table 79. Wego Healthcare Business Overview Table 80. Wego Healthcare Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Wego Healthcare Biodegradable Coronary Stents Product Portfolio Table 82. Wego Healthcare Recent Development Table 83. SMT Company Information Table 84. SMT Business Overview Table 85. SMT Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. SMT Biodegradable Coronary Stents Product Portfolio Table 87. SMT Recent Development Table 88. SINOMED Company Information Table 89. SINOMED Business Overview Table 90. SINOMED Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. SINOMED Biodegradable Coronary Stents Product Portfolio Table 92. SINOMED Recent Development Table 93. REVA Medical (1) Company Information Table 94. REVA Medical (1) Business Overview Table 95. REVA Medical (1) Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. REVA Medical (1) Biodegradable Coronary Stents Product Portfolio Table 97. REVA Medical (1) Recent Development Table 98. Q3 Medical Company Information Table 99. Q3 Medical Business Overview Table 100. Q3 Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Q3 Medical Biodegradable Coronary Stents Product Portfolio Table 102. Q3 Medical Recent Development Table 103. Lepu Medical Company Information Table 104. Lepu Medical Business Overview Table 105. Lepu Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lepu Medical Biodegradable Coronary Stents Product Portfolio Table 107. Lepu Medical Recent Development Table 108. Kyoto Medical Company Information Table 109. Kyoto Medical Business Overview Table 110. Kyoto Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Kyoto Medical Biodegradable Coronary Stents Product Portfolio Table 112. Kyoto Medical Recent Development Table 113. Elixir Medical Company Information Table 114. Elixir Medical Business Overview Table 115. Elixir Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Elixir Medical Biodegradable Coronary Stents Product Portfolio Table 117. Elixir Medical Recent Development Table 118. Cardionovum Company Information Table 119. Cardionovum Business Overview Table 120. Cardionovum Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Cardionovum Biodegradable Coronary Stents Product Portfolio Table 122. Cardionovum Recent Development Table 123. Biotronik Company Information Table 124. Biotronik Business Overview Table 125. Biotronik Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Biotronik Biodegradable Coronary Stents Product Portfolio Table 127. Biotronik Recent Development Table 128. Arterius Company Information Table 129. Arterius Business Overview Table 130. Arterius Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Arterius Biodegradable Coronary Stents Product Portfolio Table 132. Arterius Recent Development Table 133. AMG International Company Information Table 134. AMG International Business Overview Table 135. AMG International Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. AMG International Biodegradable Coronary Stents Product Portfolio Table 137. AMG International Recent Development Table 138. Amaranth Medical Company Information Table 139. Amaranth Medical Business Overview Table 140. Amaranth Medical Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Amaranth Medical Biodegradable Coronary Stents Product Portfolio Table 142. Amaranth Medical Recent Development Table 143. 3M Company Information Table 144. 3M Business Overview Table 145. 3M Biodegradable Coronary Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. 3M Biodegradable Coronary Stents Product Portfolio Table 147. 3M Recent Development Table 148. North America Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 151. North America Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 152. North America Biodegradable Coronary Stents Sales Price by Type (2021-2026) & (US$/Unit) Table 153. North America Biodegradable Coronary Stents Sales Price by Type (2027-2032) & (US$/Unit) Table 154. North America Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 155. North America Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 156. North America Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 157. North America Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 158. North America Biodegradable Coronary Stents Sales Price by Application (2021-2026) & (US$/Unit) Table 159. North America Biodegradable Coronary Stents Sales Price by Application (2027-2032) & (US$/Unit) Table 160. North America Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Biodegradable Coronary Stents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. North America Biodegradable Coronary Stents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. North America Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 164. North America Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 165. North America Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 166. North America Biodegradable Coronary Stents Sales Price by Country (2021-2026) & (US$/Unit) Table 167. North America Biodegradable Coronary Stents Sales Price by Country (2027-2032) & (US$/Unit) Table 168. United States Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 169. Canada Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 170. Mexico Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 171. Europe Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 172. Europe Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 173. Europe Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 174. Europe Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 175. Europe Biodegradable Coronary Stents Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Europe Biodegradable Coronary Stents Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Europe Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 178. Europe Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 179. Europe Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 180. Europe Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 181. Europe Biodegradable Coronary Stents Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Europe Biodegradable Coronary Stents Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Europe Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Europe Biodegradable Coronary Stents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Europe Biodegradable Coronary Stents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Europe Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 187. Europe Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 188. Europe Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 189. Europe Biodegradable Coronary Stents Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Europe Biodegradable Coronary Stents Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Germany Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 192. France Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 193. U.K. Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 194. Italy Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 195. Russia Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 196. Spain Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 197. Netherlands Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 198. Switzerland Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 199. Sweden Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 200. Poland Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 201. China Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 202. China Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 203. China Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 204. China Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 205. China Biodegradable Coronary Stents Sales Price by Type (2021-2026) & (US$/Unit) Table 206. China Biodegradable Coronary Stents Sales Price by Type (2027-2032) & (US$/Unit) Table 207. China Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 208. China Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 209. China Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 210. China Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 211. China Biodegradable Coronary Stents Sales Price by Application (2021-2026) & (US$/Unit) Table 212. China Biodegradable Coronary Stents Sales Price by Application (2027-2032) & (US$/Unit) Table 213. Asia Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 216. Asia Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 217. Asia Biodegradable Coronary Stents Sales Price by Type (2021-2026) & (US$/Unit) Table 218. Asia Biodegradable Coronary Stents Sales Price by Type (2027-2032) & (US$/Unit) Table 219. Asia Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 220. Asia Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 221. Asia Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 222. Asia Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 223. Asia Biodegradable Coronary Stents Sales Price by Application (2021-2026) & (US$/Unit) Table 224. Asia Biodegradable Coronary Stents Sales Price by Application (2027-2032) & (US$/Unit) Table 225. Asia Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. Asia Biodegradable Coronary Stents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. Asia Biodegradable Coronary Stents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. Asia Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 229. Asia Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 230. Asia Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 231. Asia Biodegradable Coronary Stents Sales Price by Country (2021-2026) & (US$/Unit) Table 232. Asia Biodegradable Coronary Stents Sales Price by Country (2027-2032) & (US$/Unit) Table 233. Japan Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 234. South Korea Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 235. India Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 236. Australia Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 237. Taiwan Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 238. Southeast Asia Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 239. SAMEA Biodegradable Coronary Stents Revenue by Type (2021-2026) & (US$ Million) Table 240. SAMEA Biodegradable Coronary Stents Revenue by Type (2027-2032) & (US$ Million) Table 241. SAMEA Biodegradable Coronary Stents Sales by Type (2021-2026) & (Units) Table 242. SAMEA Biodegradable Coronary Stents Sales by Type (2027-2032) & (Units) Table 243. SAMEA Biodegradable Coronary Stents Sales Price by Type (2021-2026) & (US$/Unit) Table 244. SAMEA Biodegradable Coronary Stents Sales Price by Type (2027-2032) & (US$/Unit) Table 245. SAMEA Biodegradable Coronary Stents Revenue by Application (2021-2026) & (US$ Million) Table 246. SAMEA Biodegradable Coronary Stents Revenue by Application (2027-2032) & (US$ Million) Table 247. SAMEA Biodegradable Coronary Stents Sales by Application (2021-2026) & (Units) Table 248. SAMEA Biodegradable Coronary Stents Sales by Application (2027-2032) & (Units) Table 249. SAMEA Biodegradable Coronary Stents Sales Price by Application (2021-2026) & (US$/Unit) Table 250. SAMEA Biodegradable Coronary Stents Sales Price by Application (2027-2032) & (US$/Unit) Table 251. SAMEA Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Biodegradable Coronary Stents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 253. SAMEA Biodegradable Coronary Stents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 254. SAMEA Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 255. SAMEA Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 256. SAMEA Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 257. SAMEA Biodegradable Coronary Stents Sales Price by Country (2021-2026) & (US$/Unit) Table 258. SAMEA Biodegradable Coronary Stents Sales Price by Country (2027-2032) & (US$/Unit) Table 259. Brazil Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 260. Argentina Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 261. Chile Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 262. Colombia Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 263. Peru Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 264. Saudi Arabia Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 265. Israel Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 266. UAE Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 267. Turkey Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 268. Iran Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 269. Egypt Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Table 270. Key Raw Materials Table 271. Raw Materials Key Suppliers Table 272. Biodegradable Coronary Stents Distributors List Table 273. Biodegradable Coronary Stents Customers List Table 274. Research Programs/Design for This Report Table 275. Authors List of This Report Table 276. Secondary Sources Table 277. Primary Sources List of Figures Figure 1. Biodegradable Coronary Stents Image Figure 2. Global Biodegradable Coronary Stents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biodegradable Coronary Stents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Polylactic Acid (PLA) Image Figure 5. Magnesium Alloys Image Figure 6. Others Image Figure 7. Global Biodegradable Coronary Stents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Biodegradable Coronary Stents Market Size Share 2021 VS 2025 VS 2032 Figure 9. Percutaneous Coronary Intervention (PCI) Image Figure 10. Post-Procedure Management Image Figure 11. Drug-Eluting Image Figure 12. Global Biodegradable Coronary Stents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biodegradable Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 14. Global Biodegradable Coronary Stents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Biodegradable Coronary Stents Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Biodegradable Coronary Stents Revenue Market Share by Region (2021-2032) Figure 17. Global Biodegradable Coronary Stents Sales (2021-2032) & (Units) Figure 18. Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 19. Global Biodegradable Coronary Stents Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Biodegradable Coronary Stents Sales YoY (2021-2032) & (Units) Figure 21. Europe Biodegradable Coronary Stents Sales YoY (2021-2032) & (Units) Figure 22. China Biodegradable Coronary Stents Sales YoY (2021-2032) & (Units) Figure 23. Asia (Excluding China) Biodegradable Coronary Stents Sales YoY (2021-2032) & (Units) Figure 24. South America, Middle East and Africa Biodegradable Coronary Stents Sales YoY (2021-2032) & (Units) Figure 25. Global Biodegradable Coronary Stents Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Biodegradable Coronary Stents Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Biodegradable Coronary Stents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Biodegradable Coronary Stents Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2032) Figure 31. Global Biodegradable Coronary Stents Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 32. Global Biodegradable Coronary Stents Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2032) Figure 34. Global Biodegradable Coronary Stents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Biodegradable Coronary Stents Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2032) Figure 37. Global Biodegradable Coronary Stents Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Biodegradable Coronary Stents Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2032) Figure 40. North America Biodegradable Coronary Stents Revenue Share by Type (2021-2032) Figure 41. North America Biodegradable Coronary Stents Sales Share by Type (2021-2032) Figure 42. North America Biodegradable Coronary Stents Revenue Share by Application (2021-2032) Figure 43. North America Biodegradable Coronary Stents Sales Share by Application (2021-2032) Figure 44. North America Biodegradable Coronary Stents Revenue Share by Country (2021-2032) Figure 45. North America Biodegradable Coronary Stents Sales Share by Country (2021-2032) Figure 46. Europe Biodegradable Coronary Stents Revenue Share by Type (2021-2032) Figure 47. Europe Biodegradable Coronary Stents Sales Share by Type (2021-2032) Figure 48. Europe Biodegradable Coronary Stents Revenue Share by Application (2021-2032) Figure 49. Europe Biodegradable Coronary Stents Sales Share by Application (2021-2032) Figure 50. Europe Biodegradable Coronary Stents Revenue Share by Country (2021-2032) Figure 51. Europe Biodegradable Coronary Stents Sales Share by Country (2021-2032) Figure 52. China Biodegradable Coronary Stents Revenue Share by Type (2021-2032) Figure 53. China Biodegradable Coronary Stents Sales Share by Type (2021-2032) Figure 54. China Biodegradable Coronary Stents Revenue Share by Application (2021-2032) Figure 55. China Biodegradable Coronary Stents Sales Share by Application (2021-2032) Figure 56. Asia Biodegradable Coronary Stents Revenue Share by Type (2021-2032) Figure 57. Asia Biodegradable Coronary Stents Sales Share by Type (2021-2032) Figure 58. Asia Biodegradable Coronary Stents Revenue Share by Application (2021-2032) Figure 59. Asia Biodegradable Coronary Stents Sales Share by Application (2021-2032) Figure 60. Asia Biodegradable Coronary Stents Revenue Share by Country (2021-2032) Figure 61. Asia Biodegradable Coronary Stents Sales Share by Country (2021-2032) Figure 62. SAMEA Biodegradable Coronary Stents Revenue Share by Type (2021-2032) Figure 63. SAMEA Biodegradable Coronary Stents Sales Share by Type (2021-2032) Figure 64. SAMEA Biodegradable Coronary Stents Revenue Share by Application (2021-2032) Figure 65. SAMEA Biodegradable Coronary Stents Sales Share by Application (2021-2032) Figure 66. SAMEA Biodegradable Coronary Stents Revenue Share by Country (2021-2032) Figure 67. SAMEA Biodegradable Coronary Stents Sales Share by Country (2021-2032) Figure 68. Biodegradable Coronary Stents Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Biodegradable Coronary Stents Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Polylactic Acid (PLA)
  • Magnesium Alloys
  • Others
Applications
  • Percutaneous Coronary Intervention (PCI)
  • Post-Procedure Management
  • Drug-Eluting
Companies covered
  • Abbott
  • Terumo
  • Shandong Huaan Biotechnology
  • Boston Scientific
  • Wego Healthcare
  • SMT
  • SINOMED
  • REVA Medical (1)
  • Q3 Medical
  • Lepu Medical
  • Kyoto Medical
  • Elixir Medical
  • Cardionovum
  • Biotronik
  • Arterius
  • AMG International
  • Amaranth Medical
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biodegradable Coronary Stents Market by Type
  3. 1.2.1 Global Biodegradable Coronary Stents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Polylactic Acid (PLA)
  5. 1.2.3 Magnesium Alloys
  6. 1.2.4 Others
  7. 1.3 Biodegradable Coronary Stents Market by Application
  8. 1.3.1 Global Biodegradable Coronary Stents Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Percutaneous Coronary Intervention (PCI)
  10. 1.3.3 Post-Procedure Management
  11. 1.3.4 Drug-Eluting
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Biodegradable Coronary Stents Market Dynamics
  1. 2.1 Biodegradable Coronary Stents Industry Trends
  2. 2.2 Biodegradable Coronary Stents Industry Drivers
  3. 2.3 Biodegradable Coronary Stents Industry Opportunities and Challenges
  4. 2.4 Biodegradable Coronary Stents Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Biodegradable Coronary Stents Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Biodegradable Coronary Stents Revenue by Region
  3. 3.2.1 Global Biodegradable Coronary Stents Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biodegradable Coronary Stents Revenue by Region (2021-2026)
  5. 3.2.3 Global Biodegradable Coronary Stents Revenue by Region (2027-2032)
  6. 3.2.4 Global Biodegradable Coronary Stents Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Biodegradable Coronary Stents Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Biodegradable Coronary Stents Sales by Region
  9. 3.4.1 Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Biodegradable Coronary Stents Sales by Region (2021-2026)
  11. 3.4.3 Global Biodegradable Coronary Stents Sales by Region (2027-2032)
  12. 3.4.4 Global Biodegradable Coronary Stents Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Biodegradable Coronary Stents Revenue by Manufacturers
  2. 4.1.1 Global Biodegradable Coronary Stents Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Biodegradable Coronary Stents Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Biodegradable Coronary Stents Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biodegradable Coronary Stents Sales by Manufacturers
  6. 4.2.1 Global Biodegradable Coronary Stents Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Biodegradable Coronary Stents Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Biodegradable Coronary Stents Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Biodegradable Coronary Stents Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Biodegradable Coronary Stents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Biodegradable Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Biodegradable Coronary Stents Manufacturers, Product Type & Application
  13. 4.7 Global Biodegradable Coronary Stents Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Biodegradable Coronary Stents Market CR5 and HHI
  16. 4.8.2 2025 Biodegradable Coronary Stents Tier 1, Tier 2, and Tier 3
5 Biodegradable Coronary Stents Market by Type
  1. 5.1 Global Biodegradable Coronary Stents Revenue by Type
  2. 5.1.1 Global Biodegradable Coronary Stents Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Biodegradable Coronary Stents Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Biodegradable Coronary Stents Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Biodegradable Coronary Stents Sales by Type
  6. 5.2.1 Global Biodegradable Coronary Stents Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biodegradable Coronary Stents Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Biodegradable Coronary Stents Sales Market Share by Type (2021-2032)
  9. 5.3 Global Biodegradable Coronary Stents Price by Type
6 Biodegradable Coronary Stents Market by Application
  1. 6.1 Global Biodegradable Coronary Stents Revenue by Application
  2. 6.1.1 Global Biodegradable Coronary Stents Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Biodegradable Coronary Stents Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Biodegradable Coronary Stents Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Biodegradable Coronary Stents Sales by Application
  6. 6.2.1 Global Biodegradable Coronary Stents Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Biodegradable Coronary Stents Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Biodegradable Coronary Stents Sales Market Share by Application (2021-2032)
  9. 6.3 Global Biodegradable Coronary Stents Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Biodegradable Coronary Stents Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Terumo
  8. 7.2.1 Terumo Company Information
  9. 7.2.2 Terumo Business Overview
  10. 7.2.3 Terumo Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Terumo Biodegradable Coronary Stents Product Portfolio
  12. 7.2.5 Terumo Recent Developments
  13. 7.3 Shandong Huaan Biotechnology
  14. 7.3.1 Shandong Huaan Biotechnology Company Information
  15. 7.3.2 Shandong Huaan Biotechnology Business Overview
  16. 7.3.3 Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio
  18. 7.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 7.4 Boston Scientific
  20. 7.4.1 Boston Scientific Company Information
  21. 7.4.2 Boston Scientific Business Overview
  22. 7.4.3 Boston Scientific Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boston Scientific Biodegradable Coronary Stents Product Portfolio
  24. 7.4.5 Boston Scientific Recent Developments
  25. 7.5 Wego Healthcare
  26. 7.5.1 Wego Healthcare Company Information
  27. 7.5.2 Wego Healthcare Business Overview
  28. 7.5.3 Wego Healthcare Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Wego Healthcare Biodegradable Coronary Stents Product Portfolio
  30. 7.5.5 Wego Healthcare Recent Developments
  31. 7.6 SMT
  32. 7.6.1 SMT Company Information
  33. 7.6.2 SMT Business Overview
  34. 7.6.3 SMT Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SMT Biodegradable Coronary Stents Product Portfolio
  36. 7.6.5 SMT Recent Developments
  37. 7.7 SINOMED
  38. 7.7.1 SINOMED Company Information
  39. 7.7.2 SINOMED Business Overview
  40. 7.7.3 SINOMED Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SINOMED Biodegradable Coronary Stents Product Portfolio
  42. 7.7.5 SINOMED Recent Developments
  43. 7.8 REVA Medical (1)
  44. 7.8.1 REVA Medical (1) Company Information
  45. 7.8.2 REVA Medical (1) Business Overview
  46. 7.8.3 REVA Medical (1) Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 REVA Medical (1) Biodegradable Coronary Stents Product Portfolio
  48. 7.8.5 REVA Medical (1) Recent Developments
  49. 7.9 Q3 Medical
  50. 7.9.1 Q3 Medical Company Information
  51. 7.9.2 Q3 Medical Business Overview
  52. 7.9.3 Q3 Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Q3 Medical Biodegradable Coronary Stents Product Portfolio
  54. 7.9.5 Q3 Medical Recent Developments
  55. 7.10 Lepu Medical
  56. 7.10.1 Lepu Medical Company Information
  57. 7.10.2 Lepu Medical Business Overview
  58. 7.10.3 Lepu Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lepu Medical Biodegradable Coronary Stents Product Portfolio
  60. 7.10.5 Lepu Medical Recent Developments
  61. 7.11 Kyoto Medical
  62. 7.11.1 Kyoto Medical Company Information
  63. 7.11.2 Kyoto Medical Business Overview
  64. 7.11.3 Kyoto Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Kyoto Medical Biodegradable Coronary Stents Product Portfolio
  66. 7.11.5 Kyoto Medical Recent Developments
  67. 7.12 Elixir Medical
  68. 7.12.1 Elixir Medical Company Information
  69. 7.12.2 Elixir Medical Business Overview
  70. 7.12.3 Elixir Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Elixir Medical Biodegradable Coronary Stents Product Portfolio
  72. 7.12.5 Elixir Medical Recent Developments
  73. 7.13 Cardionovum
  74. 7.13.1 Cardionovum Company Information
  75. 7.13.2 Cardionovum Business Overview
  76. 7.13.3 Cardionovum Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cardionovum Biodegradable Coronary Stents Product Portfolio
  78. 7.13.5 Cardionovum Recent Developments
  79. 7.14 Biotronik
  80. 7.14.1 Biotronik Company Information
  81. 7.14.2 Biotronik Business Overview
  82. 7.14.3 Biotronik Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Biotronik Biodegradable Coronary Stents Product Portfolio
  84. 7.14.5 Biotronik Recent Developments
  85. 7.15 Arterius
  86. 7.15.1 Arterius Company Information
  87. 7.15.2 Arterius Business Overview
  88. 7.15.3 Arterius Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Arterius Biodegradable Coronary Stents Product Portfolio
  90. 7.15.5 Arterius Recent Developments
  91. 7.16 AMG International
  92. 7.16.1 AMG International Company Information
  93. 7.16.2 AMG International Business Overview
  94. 7.16.3 AMG International Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AMG International Biodegradable Coronary Stents Product Portfolio
  96. 7.16.5 AMG International Recent Developments
  97. 7.17 Amaranth Medical
  98. 7.17.1 Amaranth Medical Company Information
  99. 7.17.2 Amaranth Medical Business Overview
  100. 7.17.3 Amaranth Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Amaranth Medical Biodegradable Coronary Stents Product Portfolio
  102. 7.17.5 Amaranth Medical Recent Developments
  103. 7.18 3M
  104. 7.18.1 3M Company Information
  105. 7.18.2 3M Business Overview
  106. 7.18.3 3M Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 3M Biodegradable Coronary Stents Product Portfolio
  108. 7.18.5 3M Recent Developments
8 North America
  1. 8.1 North America Biodegradable Coronary Stents Market Size by Type
  2. 8.1.1 North America Biodegradable Coronary Stents Revenue by Type (2021-2032)
  3. 8.1.2 North America Biodegradable Coronary Stents Sales by Type (2021-2032)
  4. 8.1.3 North America Biodegradable Coronary Stents Price by Type (2021-2032)
  5. 8.2 North America Biodegradable Coronary Stents Market Size by Application
  6. 8.2.1 North America Biodegradable Coronary Stents Revenue by Application (2021-2032)
  7. 8.2.2 North America Biodegradable Coronary Stents Sales by Application (2021-2032)
  8. 8.2.3 North America Biodegradable Coronary Stents Price by Application (2021-2032)
  9. 8.3 North America Biodegradable Coronary Stents Market Size by Country
  10. 8.3.1 North America Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Biodegradable Coronary Stents Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Biodegradable Coronary Stents Market Size by Type
  2. 9.1.1 Europe Biodegradable Coronary Stents Revenue by Type (2021-2032)
  3. 9.1.2 Europe Biodegradable Coronary Stents Sales by Type (2021-2032)
  4. 9.1.3 Europe Biodegradable Coronary Stents Price by Type (2021-2032)
  5. 9.2 Europe Biodegradable Coronary Stents Market Size by Application
  6. 9.2.1 Europe Biodegradable Coronary Stents Revenue by Application (2021-2032)
  7. 9.2.2 Europe Biodegradable Coronary Stents Sales by Application (2021-2032)
  8. 9.2.3 Europe Biodegradable Coronary Stents Price by Application (2021-2032)
  9. 9.3 Europe Biodegradable Coronary Stents Market Size by Country
  10. 9.3.1 Europe Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Biodegradable Coronary Stents Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Biodegradable Coronary Stents Market Size by Type
  2. 10.1.1 China Biodegradable Coronary Stents Revenue by Type (2021-2032)
  3. 10.1.2 China Biodegradable Coronary Stents Sales by Type (2021-2032)
  4. 10.1.3 China Biodegradable Coronary Stents Price by Type (2021-2032)
  5. 10.2 China Biodegradable Coronary Stents Market Size by Application
  6. 10.2.1 China Biodegradable Coronary Stents Revenue by Application (2021-2032)
  7. 10.2.2 China Biodegradable Coronary Stents Sales by Application (2021-2032)
  8. 10.2.3 China Biodegradable Coronary Stents Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biodegradable Coronary Stents Market Size by Type
  2. 11.1.1 Asia Biodegradable Coronary Stents Revenue by Type (2021-2032)
  3. 11.1.2 Asia Biodegradable Coronary Stents Sales by Type (2021-2032)
  4. 11.1.3 Asia Biodegradable Coronary Stents Price by Type (2021-2032)
  5. 11.2 Asia Biodegradable Coronary Stents Market Size by Application
  6. 11.2.1 Asia Biodegradable Coronary Stents Revenue by Application (2021-2032)
  7. 11.2.2 Asia Biodegradable Coronary Stents Sales by Application (2021-2032)
  8. 11.2.3 Asia Biodegradable Coronary Stents Price by Application (2021-2032)
  9. 11.3 Asia Biodegradable Coronary Stents Market Size by Country
  10. 11.3.1 Asia Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Biodegradable Coronary Stents Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biodegradable Coronary Stents Market Size by Type
  2. 12.1.1 SAMEA Biodegradable Coronary Stents Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Biodegradable Coronary Stents Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Biodegradable Coronary Stents Price by Type (2021-2032)
  5. 12.2 SAMEA Biodegradable Coronary Stents Market Size by Application
  6. 12.2.1 SAMEA Biodegradable Coronary Stents Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Biodegradable Coronary Stents Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Biodegradable Coronary Stents Price by Application (2021-2032)
  9. 12.3 SAMEA Biodegradable Coronary Stents Market Size by Country
  10. 12.3.1 SAMEA Biodegradable Coronary Stents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Biodegradable Coronary Stents Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Biodegradable Coronary Stents Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Biodegradable Coronary Stents Value Chain Analysis
  2. 13.1.1 Biodegradable Coronary Stents Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Biodegradable Coronary Stents Production Mode & Process
  6. 13.2 Biodegradable Coronary Stents Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Biodegradable Coronary Stents Distributors
  9. 13.2.3 Biodegradable Coronary Stents Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research